September 2026 FDA Recall Paroxetine Hydrochloride by Apotex Corp.
D-0877-2026 - Failed dissolution specifications.

This Class II drug recall was voluntarily initiated by Apotex Corp. on September 23, 2026 for the product Paroxetine Hydrochloride. The FDA reported the reason for recall as failed dissolution specifications.. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0877-2026

Reason for Recall
Failed dissolution specifications.
Initiated
09-23-2026
Reported
10-07-2026
Quantity

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3

Batch or Lot Expiration Information

Lot# TY9495, Exp Date: 05/2027.